Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-03 Sale | 2024-06-05 4:53 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $30.32 | $75,793 | 9,000 (Indirect Direct) | View |
2024-03-01 Sale | 2024-03-05 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $34 | $85,000 | 11,500 (Indirect Direct) | View |
2023-12-18 Sale | 2023-12-20 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,000 | $40 | $80,000 | 14,000 (Indirect Direct) | View |
2023-12-01 Sale | 2023-12-05 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $29.4 | $73,500 | 16,000 (Indirect Direct) | View |
2023-09-05 Sale | 2023-09-07 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $30 | $75,000 | 18,500 (Indirect Direct) | View |
2021-05-14 Purchase | 2021-05-18 3:19 pm | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 20,000 | $10.13 | $202,650 | 1,722,565 (Indirect Direct) | View |
2021-02-17 Purchase | 2021-02-19 6:18 pm | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 312,500 | $16 | $5,000,000 | 312,500 (Indirect) | View |
2021-02-17 Purchase | 2021-02-18 6:21 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 16,000 | $62.5 | $1,000,000 | 21,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-21 Option Award | 2024-06-25 5:42 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 26,014 | $0 | 26,014 (Direct) | View |
2023-06-21 Option Award | 2023-06-23 4:24 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 51,501 | $0 | 51,501 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 5:29 pm | N/A 2033-06-09 | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 95,000 | $0 | 95,000 (Direct) | View |
2023-04-27 Option Award | 2023-05-01 4:20 pm | N/A 2033-04-27 | Invitae Corp | NVTA | Scott Randal W. Director | 186,028 | $0 | 336,828 (Direct) | View |
2022-07-16 Option Award | 2022-07-19 6:48 pm | N/A 2032-07-16 | Invitae Corp | NVTA | Scott Randal W. Director | 80,805 | $0 | 177,805 (Direct) | View |
Ownership | 2022-07-19 6:47 pm | N/A N/A | Invitae Corp | NVTA | Scott Randal W. Director | 0 | $0 | 178,000 (Direct) | View |
2022-06-22 Option Award | 2022-06-24 4:37 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 104,921 | $0 | 104,921 (Direct) | View |
2022-06-10 Option Award | 2022-06-13 5:41 pm | N/A 2032-06-09 | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 95,000 | $0 | 95,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-22 6:47 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 38,895 | $0 | 38,895 (Direct) | View |
2021-02-17 Conversion | 2021-02-19 6:18 pm | N/A N/A | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 3,377,858 | $0 | 312,500 (Indirect) | View |
Ownership | 2021-02-11 7:15 pm | N/A 2030-02-11 | Talis Biomedical Corp | TLIS | Scott Randal W. Director | 0 | $0 | 2,131,573 (Direct) | View |
2020-06-23 Option Award | 2020-06-25 4:41 pm | N/A 2030-06-22 | BridgeBio Pharma Inc. | BBIO | Scott Randal W Director | 101,223 | $0 | 101,223 (Direct) | View |
Ownership | 2020-06-25 4:36 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Scott Randal W Director | 0 | $0 | 5,000 (Direct) | View |